Tags

Type your tag names separated by a space and hit enter

Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk?
Curr Vasc Pharmacol 2010; 8(5):720-30CV

Abstract

Vitamin D deficiency is a well-established risk factor for bone disease. Emerging data suggest a pleiotropic role of this agent in a variety of functions in humans. Epidemiological studies indicate an inverse association between vitamin D deficiency and the prevalence of cardiovascular disease (CVD), as well as individual cardiometabolic risk factors, such as hypertension, diabetes, dyslipidemia and the metabolic syndrome. Moreover, vitamin D deficiency has been implicated in the atherosclerotic process. This review considers current data regarding the role of vitamin D deficiency in the development of CVD and addresses the effect of supplementation on cardiovascular outcomes.

Authors+Show Affiliations

Endocrinology Clinic, Hippokration Hospital, Thessaloniki, Greece. anagnwstis.pan@yahoo.grNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

20180765

Citation

Anagnostis, Panagiotis, et al. "Vitamin D and Cardiovascular Disease: a Novel Agent for Reducing Cardiovascular Risk?" Current Vascular Pharmacology, vol. 8, no. 5, 2010, pp. 720-30.
Anagnostis P, Athyros VG, Adamidou F, et al. Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk? Curr Vasc Pharmacol. 2010;8(5):720-30.
Anagnostis, P., Athyros, V. G., Adamidou, F., Florentin, M., & Karagiannis, A. (2010). Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk? Current Vascular Pharmacology, 8(5), pp. 720-30.
Anagnostis P, et al. Vitamin D and Cardiovascular Disease: a Novel Agent for Reducing Cardiovascular Risk. Curr Vasc Pharmacol. 2010;8(5):720-30. PubMed PMID: 20180765.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Vitamin D and cardiovascular disease: a novel agent for reducing cardiovascular risk? AU - Anagnostis,Panagiotis, AU - Athyros,Vasilios G, AU - Adamidou,Fotini, AU - Florentin,Matilda, AU - Karagiannis,Asterios, PY - 2010/02/05/received PY - 2010/02/15/accepted PY - 2010/2/26/entrez PY - 2010/2/26/pubmed PY - 2010/12/14/medline SP - 720 EP - 30 JF - Current vascular pharmacology JO - Curr Vasc Pharmacol VL - 8 IS - 5 N2 - Vitamin D deficiency is a well-established risk factor for bone disease. Emerging data suggest a pleiotropic role of this agent in a variety of functions in humans. Epidemiological studies indicate an inverse association between vitamin D deficiency and the prevalence of cardiovascular disease (CVD), as well as individual cardiometabolic risk factors, such as hypertension, diabetes, dyslipidemia and the metabolic syndrome. Moreover, vitamin D deficiency has been implicated in the atherosclerotic process. This review considers current data regarding the role of vitamin D deficiency in the development of CVD and addresses the effect of supplementation on cardiovascular outcomes. SN - 1875-6212 UR - https://www.unboundmedicine.com/medline/citation/20180765/Vitamin_D_and_cardiovascular_disease:_a_novel_agent_for_reducing_cardiovascular_risk L2 - http://www.eurekaselect.com/86631/article DB - PRIME DP - Unbound Medicine ER -